Mechanisms of action Preclinical studies document: Anxiolytic effect without sedation in classical tests (elevated plus maze, open field, light-dark box) GABAergic system modulation : allosteric potentiation of GABA-A observed ex vivo Enkephalin increase (endogenous opioid peptide) and serotonergic modulation Immunomodulatory effects inherited from tuftsin: macrophage activation, T-helper modulation Behavioural models Anxiolysis is measured via time spent in open arms of the elevated plus maze (EPM), visit ratio of central zones of open field , and exit latency in light-dark box
This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
This inefficiency means you need to take significantly higher doses to achieve therapeutic levels in your blood, which can be both costly and ineffective
Other resolutions: 250 462 pixels | 330 609 pixels | 500 923 pixels | 960 1,772 pixels | 1,280 2,363 pixels
, BDNF HGF ,
Thus, treatment resistant symptoms in major depressive disorder or other mood disorders may potentially be addressed with DSIP [10]
